(Reuters) -Viatris said on Monday the U.S. Food and Drug Administration has restricted imports of 11 products made at the drugmaker's facility in India after the regulator's inspection found it ...
Viatris disclosed that its manufacturing facility in Indore, India, was issued a warning letter from the FDA, which banned 11 products that are produced at the site from being imported into the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback